<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04847362</url>
  </required_header>
  <id_info>
    <org_study_id>11.04.2021-27076</org_study_id>
    <nct_id>NCT04847362</nct_id>
  </id_info>
  <brief_title>The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic</brief_title>
  <official_title>Investigation of the Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic on the Depression, Attachment and Anxiety Levels of Women: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saglik Bilimleri Universitesi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saglik Bilimleri Universitesi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the planned study, it was aimed to examine the effect of tele-education offered in the&#xD;
      postpartum period in the covid 19 pandemic on the levels of depression, attachment and&#xD;
      anxiety of women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the planned study, it was aimed to examine the effect of tele-education offered in the&#xD;
      postpartum period in the covid 19 pandemic on the levels of depression, attachment and&#xD;
      anxiety of women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postpartum depression</measure>
    <time_frame>postpartum 6 weeks</time_frame>
    <description>The Edinburgh Postnatal Depression Scale (EPDS) was used to detect depressive symptoms during the postpartum period [30]. EPDS is a 10-item questionnaire assessing the interviewee's depressive feelings from the seven days before the interview. The response of the questions is scored from 0-3, with higher scores indicating higher levels of depressive symptoms. The total EPDS score of a respondentcan range from 0 to 30.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postpartum depression</measure>
    <time_frame>postpartum 3 months</time_frame>
    <description>The Edinburgh Postnatal Depression Scale (EPDS) was used to detect depressive symptoms during the postpartum period [30]. EPDS is a 10-item questionnaire assessing the interviewee's depressive feelings from the seven days before the interview. The response of the questions is scored from 0-3, with higher scores indicating higher levels of depressive symptoms. The total EPDS score of a respondentcan range from 0 to 30.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postpartum mother-baby attachment</measure>
    <time_frame>postpartum 6 weeks a</time_frame>
    <description>Postpartum Attachment Scale: Early diagnosis of problems in mother-infant relationship Developed to provide and maternal filling4. The scale is a six-digit It has a Likert scale. Scale &quot;always&quot;, Postpartum attachment scales in mothers 247 &quot;Very often&quot;, &quot;often&quot;, &quot;sometimes&quot;, &quot;rarely&quot;, &quot;no It has been defined as &quot;time&quot;. Items 0-5 It is rated as. Scale 17 is reverse It consists of 25 graded items. Scale &quot;attachment disorder&quot; (12 items), &quot;Rejection and irritability&quot; (seven items), &quot;care tension about &quot;(four items), abuse four sub-categories with risk (two substances) It consists of units. Pathology in mother-infant relationship cut point specified for four subscales 4'18 The cut-off point of four subscales attachment disorder (subscale 1), respectively&gt; 12, rejection and irritability (subscale 2)&gt; 17, anxiety in infant care (subscale 3)&gt; 10, the risk of abuse (subscale 4) is&gt; 3.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postpartum mother-baby attachment</measure>
    <time_frame>postpartum 3 months</time_frame>
    <description>Postpartum Attachment Scale: Early diagnosis of problems in mother-infant relationship Developed to provide and maternal filling4. The scale is a six-digit It has a Likert scale. Scale &quot;always&quot;, Postpartum attachment scales in mothers 247 &quot;Very often&quot;, &quot;often&quot;, &quot;sometimes&quot;, &quot;rarely&quot;, &quot;no It has been defined as &quot;time&quot;. Items 0-5 It is rated as. Scale 17 is reverse It consists of 25 graded items. Scale &quot;attachment disorder&quot; (12 items), &quot;Rejection and irritability&quot; (seven items), &quot;care tension about &quot;(four items), abuse four sub-categories with risk (two substances) It consists of units. Pathology in mother-infant relationship cut point specified for four subscales 4'18 The cut-off point of four subscales attachment disorder (subscale 1), respectively&gt; 12, rejection and irritability (subscale 2)&gt; 17, anxiety in infant care (subscale 3)&gt; 10, the risk of abuse (subscale 4) is&gt; 3.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anxiety state</measure>
    <time_frame>postpartum 6 weeks</time_frame>
    <description>State Anxiety Scale (STAI-I) in 1970 Turkish form developed by Spielberger Oner N et al. Its validity and reliability study has been carried out by adapting it. Anxiety level In STAI-I, &quot;(1) not at all, (2) a little, (3) a lot and (4) completely&quot; While it is scored as, the options in STAI-II are (1) almost never, (2) sometimes, (3) a lot of time, and (4) it is almost always. 2 kinds of scales Scores obtained from both scales theoretically it ranges from 20 to 80. High score indicates high anxiety level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anxiety state</measure>
    <time_frame>postpartum 3 months</time_frame>
    <description>State Anxiety Scale (STAI-I) in 1970 Turkish form developed by Spielberger Oner N et al. Its validity and reliability study has been carried out by adapting it. Anxiety level In STAI-I, &quot;(1) not at all, (2) a little, (3) a lot and (4) completely&quot; While it is scored as, the options in STAI-II are (1) almost never, (2) sometimes, (3) a lot of time, and (4) it is almost always. 2 kinds of scales Scores obtained from both scales theoretically it ranges from 20 to 80. High score indicates high anxiety level</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Postpartum Depression</condition>
  <condition>Anxiety State</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The mothers in this group will be given telehealth training for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Mothers in this group will not be given telehealth education, they will receive care within the scope of routine care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Experimental</intervention_name>
    <description>education group</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion Criteria&#xD;
&#xD;
          -  literate&#xD;
&#xD;
          -  Giving birth at term (between 38-42 weeks of gestation)&#xD;
&#xD;
          -  Being on the 7th Postpartum Day,&#xD;
&#xD;
          -  Participation in the study is voluntary,&#xD;
&#xD;
          -  Absence of any psychiatric illness,&#xD;
&#xD;
          -  Women who have characteristics such as not using any psychiatric medication.&#xD;
&#xD;
          -  Baby with normal birth weight and APGAR score of 8 and above&#xD;
&#xD;
          -  Those who have not developed postpartum complications&#xD;
&#xD;
          -  Speaks and understands Turkish&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        women who do not meet the sample selection criteria&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zeynep Kamil Women's and Children's Diseases Training and Research Hospital</name>
      <address>
        <city>Ä°stanbul</city>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LEYLA KAYA</last_name>
      <phone>+90 5456439482</phone>
      <email>leylakaya02@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SaglÄ±k Bilimleri Universitesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YASEMÄ°N AYDIN KARTAL</last_name>
      <phone>+90 5432870029</phone>
      <email>yasemin.aydin@sbu.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 15, 2021</last_update_submitted>
  <last_update_submitted_qc>April 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saglik Bilimleri Universitesi</investigator_affiliation>
    <investigator_full_name>YASEMÄ°N AYDIN KARTAL</investigator_full_name>
    <investigator_title>ASSOCIATE PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>postpartum depression</keyword>
  <keyword>mother-baby attachment</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Depression, Postpartum</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

